SMS Pharmaceuticals Ltd

NSE: SMSPHARMA · BSE: 532815 · Pharmaceuticals & Biotechnology · 25 announcements

Share price: ₹471.50
Market cap: ₹4,180 Cr
Revenue (annual): ₹886.9 Cr
Net profit (annual): ₹102.0 Cr
P/E (TTM): 40.8×Sector 47.4×
Promoter holding: 68.07%+0.00% QoQ
FII holding: 0.65%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

31 Jul 2026 17:14 IST NSE

SMS Pharmaceuticals Q1 FY27 Results: Net Profit ₹20.9 Cr, Up 2.0% YoY

SMS Pharmaceuticals Ltd reported revenue from operations of ₹207 Cr (+5.6% YoY) and net profit of ₹20.9 Cr (+2.0% YoY) for Q1 FY27.

Key figure: Net profit ₹20.9 Cr · +2.0% YoY

Open full results → Read the filing ↗

22 May 2026 13:48 IST BSE

Financial ResultsAlfa Alert

SMS Pharmaceuticals Q4 FY26 Results: Net Profit ₹32.7 Cr, Up 61.1% YoY

SMS Pharmaceuticals Ltd reported revenue from operations of ₹237.9 Cr (-4.1% YoY) and net profit of ₹32.7 Cr (+61.1% YoY) for Q4 FY26.

Key figure: Net profit ₹32.7 Cr · +61.1% YoY

Open full results → Read the filing ↗

22 May 2026 13:48 IST BSE

Financial Results

SMS Pharmaceuticals Financial Results

SMS Pharmaceuticals reported audited FY26 results and recommended a ₹0.40 per share final dividend. The company also approved shifting its registered office within Hyderabad.

Value: ₹0.40 Cr

Read the filing ↗